Migration and infectious diseases

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994 C. Ramière, L. Roche,

E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, N. Rastogi

I.J. Schalk Clinical Microbiology and Infection

Multidrug-resistant tuberculosis and migration to Europe

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004–2011 in Guangzhou, China Y.-F. Wang, H.-F. Xu, Z.-G.

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

Refugee crisis and re-emergence of forgotten infections in Europe

Mcr-1 is borne by highly diverse Escherichia coli isolates since 2004 in food-producing animals in Europe F. El Garch, M. Sauget, D. Hocquet, D. LeChaudee,

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

R. Cantón Clinical Microbiology and Infection

Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua

I. Bozicevic, S. Handanagic, S.Z. Lepej, J. Begovac

Louis Pasteur, from crystals of life to vaccination

Hexavalent vaccines for immunization in paediatric age

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

P. O'Connor, D. Jankovic, M. Muscat, M. Ben-Mamou, S. Reef, M

Vector control: a cornerstone in the malaria elimination campaign

The role of vaccination in preventing pneumococcal disease in adults

Towards the risk of yellow fever transmission in Europe

P.L. Lopalco, P. Carrillo Santisteve

Differential findings regarding molecular epidemiology of tuberculosis between two consecutive periods in the context of steady increase of immigration

P. Carrillo-Santisteve, P.L. Lopalco

Isospora belli Clinical Microbiology and Infection

A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Can we control all-cause meningococcal disease in Europe?

I. Bozicevic, S. Handanagic, S.Z. Lepej, J. Begovac

Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients.

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Racial and ethnic disparities in childhood immunization rates have declined as overall coverage increased. Percentage of children ages 19 to 35 months.

Hepatitis B and C virus-related carcinogenesis

Previously unknown species of Aspergillus

Sexually acquired Zika virus: a systematic review

Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes J. Freeman, J. Vernon, K. Morris, S.

Systematic review of antibiotic consumption in acute care hospitals

The role of antimalarial treatment in the elimination of malaria

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona S. Borrell, G. Tudó, E. Rey, J. González-Martín

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Vaccinations against respiratory tract infections at Hajj

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Tuberculosis in HIV-infected patients: a comprehensive review

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Survival of rhinoviruses on human fingers

Virology: a scientific discipline facing new challenges

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

The state of measles and rubella in the WHO European Region, 2013

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Migration and infectious diseases F. Castelli, G. Sulis Clinical Microbiology and Infection Volume 23, Issue 5, Pages 283-289 (May 2017) DOI: 10.1016/j.cmi.2017.03.012 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Estimated coverage rates for MCV1, HepB3 and DTP3 in the top three countries of origin for refugees and asylum seekers in 2015. Such estimates are based on a combination of official government information, administrative coverage data and periodic surveys and refer to the paediatric population aged 12–23 months (Source: WHO/UNICEF, http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragemcv1.html) Abbreviations: MCV1, measles-containing vaccine first dose; HepB3, hepatitis B third dose; DTP3, diphtheria/ tetanus/ pertussis third dose. Clinical Microbiology and Infection 2017 23, 283-289DOI: (10.1016/j.cmi.2017.03.012) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Proportion of new human immunodeficiency virus (HIV) infections diagnosed among native and foreign-born individuals in five of the eight European countries with the largest migrant population, in 2014. Note: data from Kazakhstan, Russian Federation and Ukraine were not available. (Source: ECDC 2015, http://ecdc.europa.eu/en/publications/Publications/hiv-aids-surveillance-in-Europe-2014.pdf). Clinical Microbiology and Infection 2017 23, 283-289DOI: (10.1016/j.cmi.2017.03.012) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Proportion of tuberculosis (TB) cases diagnosed among foreign-born individuals in the top-five EU countries with the largest migrant populations. *Data from France, Germany, Spain and the UK refer to 2014, data from Italy refer to 2013. (Source: ECDC 2016 http://ecdc.europa.eu/en/publications/Publications/ecdc-tuberculosis-surveillance-monitoring-Europe-2016.pdf). Clinical Microbiology and Infection 2017 23, 283-289DOI: (10.1016/j.cmi.2017.03.012) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions